Detalhe da pesquisa
1.
Targeting N6-methyladenosine reader YTHDF1 with siRNA boosts antitumor immunity in NASH-HCC by inhibiting EZH2-IL-6 axis.
J Hepatol
; 79(5): 1185-1200, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37459919
2.
YTHDF1 promotes intrahepatic cholangiocarcinoma progression via regulating EGFR mRNA translation.
J Gastroenterol Hepatol
; 37(6): 1156-1168, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35233828
3.
TERT promoter methylation is associated with high expression of TERT and poor prognosis in papillary thyroid cancer.
Front Oncol
; 14: 1325345, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38313800
4.
METTL3-m6A-EGFR-axis drives lenvatinib resistance in hepatocellular carcinoma.
Cancer Lett
; 559: 216122, 2023 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36898427